Phase I Study Of The Aurora Kinases (Aks) Inhibitor Pha-739358 Administered As A 6 And 3-H Iv Infusion On Days 1, 8, 15 Every 4 Wks In Patients With Advanced Solid Tumors
JOURNAL OF CLINICAL ONCOLOGY(2008)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要